Yujun Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yujun Li has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Wenping Kao
Department of Microbiology, Harbin Medical University; Key Lab for Infection and Immunity of Heilongjiang Province, Key Lab for Pathogenic Biology of Heilongjiang Province Education Bureau, Harbin, China
3 shared publications- Fengmin Zhang
Heilongjiang Provincial Key Laboratory of Infection and Immunity, Department of Microbiology, School of Basic Medical Sciences, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150081, China
2 shared publications Jun Qian
The Key Laboratory of Pathogenic Biology, Heilongjiang Higher Education Institutions, China
2 shared publicationsQingmeng Zhang
The Heilongjiang Key Laboratory of Immunity and Infection, Heilongjiang, China
2 shared publications- Wuqi Song
Department of Microbiology, Wu Lien-Teh Institute, Harbin Medical University, Harbin, China.
2 shared publications Yunlong Hu
Department of Microbiology, Harbin Medical University, China
2 shared publications
Latest Publications
- 1 October 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 139 (1) , 127-133
NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling
- 1 October 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 139 (1) , 127-133
NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling
- Open Access
- 7 February 2015
- Published by SynthesisHub Advance Scientific Research in European Journal of Molecular & Clinical Medicine
- Vol. 2 (2) , 65
Anti-tumor effects of the human monoclonal anti-nuclear antibody on the HEp-2 cells
Function of autoantibodies from patients with autoimmune diseases in malignancies development is not clear yet. It has been reported that a cell-penetrating lupus autoantibody, 3E10, which was isolated from a mouse model of systemic lupus erythematosus (SLE), has been a potential targeted therapy for DNA-repair deficient malignancies. We have got four human monoclonal antinuclear antibodies from patients with autoimmune disease, 3B5, 3C1, 3E8 and 4F3. Our data showed that four antibodies could combine HEp-2 cells and display different nuclear types as antinuclear antibody (ANA). Also, these four ANAs can inhibit HEp-2 cells proliferation. We think these antibodies may be potential antibody drugs to cancer therapy. However, the function and mechanism are not clear. Further study, we want to clarify the effects of four ANAs on proliferation of various cancers cells and to investigate the mechanism of four ANAs affecting various cancers cells proliferation and their targets. This may be a new mechanism of malignancies development in patients with autoimmune diseases, and provide novel angle of autoantibody function study.
- 7 February 2015
- Published by SynthesisHub Advance Scientific Research in European Journal of Molecular & Clinical Medicine
- Vol. 2 (2) , 65
Open AccessAnti-tumor effects of the human monoclonal anti-nuclear antibody on the HEp-2 cells
Function of autoantibodies from patients with autoimmune diseases in malignancies development is not clear yet. It has been reported that a cell-penetrating lupus autoantibody, 3E10, which was isolated from a mouse model of systemic lupus erythematosus (SLE), has been a potential targeted therapy for DNA-repair deficient malignancies. We have got four human monoclonal antinuclear antibodies from patients with autoimmune disease, 3B5, 3C1, 3E8 and 4F3. Our data showed that four antibodies could combine HEp-2 cells and display different nuclear types as antinuclear antibody (ANA). Also, these four ANAs can inhibit HEp-2 cells proliferation. We think these antibodies may be potential antibody drugs to cancer therapy. However, the function and mechanism are not clear. Further study, we want to clarify the effects of four ANAs on proliferation of various cancers cells and to investigate the mechanism of four ANAs affecting various cancers cells proliferation and their targets. This may be a new mechanism of malignancies development in patients with autoimmune diseases, and provide novel angle of autoantibody function study.
- 6 September 2013
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 438 (4) , 619-623
Borna disease virus nucleoprotein inhibits type I interferon induction through the interferon regulatory factor 7 pathway
- 6 September 2013
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 438 (4) , 619-623
Borna disease virus nucleoprotein inhibits type I interferon induction through the interferon regulatory factor 7 pathway
- 1 August 2013
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 45 (8) , 1546-1555
MAVS-mediated host cell defense is inhibited by Borna disease virus
- 1 August 2013
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 45 (8) , 1546-1555
MAVS-mediated host cell defense is inhibited by Borna disease virus